Acadian Asset Management LLC Unity Biotechnology, Inc. Transaction History

Acadian Asset Management LLC

  • $32.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.4 - $4.27 $13,470 - $143,792
33,675 Added 7.41%
487,959 $191,000
Q2 2022

Aug 09, 2022
BUY
$0.56 - $1.29 $36,058 - $83,064
64,391 Added 16.52%
454,284 $256,000
Q1 2022

May 12, 2022
BUY
$0.72 - $1.86 $79,989 - $206,640
111,097 Added 39.85%
389,893 $435,000
Q4 2021

Feb 10, 2022
BUY
$1.3 - $3.17 $362,434 - $883,783
278,796 New
278,796 $405,000

Others Institutions Holding UBX

# of Institutions
1
Shares Held
4.41M
Call Options Held
0
Put Options Held
0
View Full List

About Unity Biotechnology, Inc.

UBX Quotes by TradingView
  • Ticker UBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,036,200
  • Market Cap $14M
  • Description
  • Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...
More about UBX
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email